A Phase 3 interventional study of Ferrous sulphate and Ferrous sulphate in Iron Deficiency Anemia and Iron Deficiency Anemia Treatment, sponsored by University of Child Health Sciences and Children's Hospital, Lahore. Completed at 1 site in Pakistan. Open to participants aged 1 Day to 5 Years. Per ClinicalTrials.gov, last updated 2026-06-16.
Sponsored by University of Child Health Sciences and Children's Hospital, Lahore · Phase 3, Interventional, and Treatment
Among 38 studies testing ferrous sulfate in Anemia, Iron-Deficiency — 5 open to participants now, 5 under way, 1 of them phase 3. ferrous sulfate · Anemia, Iron-Deficiency.
Among the 38 studies testing ferrous sulfate in Anemia, Iron-Deficiency, this one is the 21st largest by enrollment of the 37 interventional ones that give a count, is the only one that started in 2025, is one of 6 in phase 3, and was the 35th registered.
600 studies on the registry are indexed under Anemia, Iron-Deficiency; 95 are open to participants now.
Browse Anemia, Iron-Deficiency studies →5 of the 38 studies testing ferrous sulfate in Anemia, Iron-Deficiency are open now, in 2 countries. Recruiting first, the newest first:
AdventHealth · Sites in United States
Ages 29 wk–33 wk
Arooj Khan · Sites in Pakistan
Ages 6 mo–5 yrs · Healthy volunteers
Auerbach Hematology Oncology Associates P C · Sites in United States
Ages 18+
Pakistan Air Force (PAF) Hospital Islamabad · Sites in Pakistan
Ages 18–40 · Women only
Shaheed Zulfiqar Ali Bhutto Medical University
Ages 6 mo–60 mo
By country, each count listing its studies:
ferrous sulfate: first FDA approval 1946 (FOLVRON). What it is approved for, and how studies give it, is on its page →
Of the 54 Anemia, Iron-Deficiency studies recruiting now, 19 (35%) set no upper age limit and 31 (57%) stop at 75 or younger; 15 take children under 18; 17 take healthy volunteers.
This study: 1 Day to 5 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
38 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 1 · Phase 2 5 · Phase 3 9 · Phase 4 8
First in 2007; this study’s year is marked. 1 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 60 is below the median of 100 across 459 interventional studies indexed under Anemia, Iron-Deficiency.
Median enrollment 80 across the 37 interventional studies. Of the 31 that completed or were terminated, 10 (32%) have results posted.
This tab as a report to print or save as PDF → With an account.
6 of 38 have an industry lead sponsor. The 10 most frequent:
University of Child Health Sciences and Children's Hospital, Lahore is the lead sponsor of 11 studies on the registry; 4 are open to participants now.
University of Child Health Sciences and Children's Hospital, Lahore has 1 study filed under Anemia, Iron-Deficiency — fewer than ten, so there is no comparison to draw.
2 of the studies testing ferrous sulfate in Anemia, Iron-Deficiency that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07657455Pakistan Air Force (PAF) Hospital IslamabadDaily Versus Alternate-Day Oral Iron Therapy for Anemia in Second-Trimester Pregnancy | 2026-12 |
| NCT07816601AdventHealthDonor Breast Milk 2 | 2027-11 |
Add all 2 to your calendar (.ics) → With an account.
Among the 38 studies testing ferrous sulfate in Anemia, Iron-Deficiency, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
Treating iron deficiency anemia in children with daily and alternate day oral iron therapy
Comparison of effectiveness of oral iron in daily and alternate group in children
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Cancer (malignancy)
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Oral iron daily dosing 6mg/kg/day
Drug: Ferrous sulphate
Oral iron therapy on alternate day with dose of 6mg /kg/day for 3 mons
Drug: Ferrous sulphate
Continuous vs intermittent oral iron therapy to see the difference of Hemoglobin rose in both group
Also known as: Daily dosing
Pattern of Rise in hemoglobin in alternate day doaung
Also known as: Intermittent, alternate day dosing
Rise in hemoglobin level after oral iron
Hemoglobin level change in g/dl
Time frame: 3 months
Change in Hemoglobin level
Hb rise in g/dl
Time frame: 3month
Rise in ferritin level
Ferritin level change in ng/ml
Time frame: 3 month
Plan to share: No — Confidentiality
No publications or documents are linked to this record.
Ran from Jan 2025 to primary completion in Mar 2025, 2 months.
Of 48 phase 3 interventional studies under Anemia, Iron-Deficiency, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 41. This study's 2 months is below that.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Ferrous sulfate
University of Child Health Sciences and Children's Hospital, Lahore